Next Article in Journal
1,1′-{1,4-Phenylene bis[3-(6-chloro-2-methyl-4-phenylquinolin-3-yl)-4,5-dihydro-1H-pyrazole-5,1-diyl]}dibutan-1-one
Previous Article in Journal
3,4-Dihydro-3-(2-hydroxyethyl)-4-(nitromethyl)quinazolin-2(1H)-one
Open AccessShort Note

1-(3-Amino-1-phenylpropyl)-3-(2-fluorophenyl)-1,3-dihydro-2H-benzimidazol-2-one

1
Department of Biomedical Imaging and Image-guided Therapy, Division of Nuclear Medicine, Medical University of Vienna, Waehringer Guertel 18-20, 1090 Vienna, Austria
2
Division of Drug Synthesis, Department of Pharmaceutical Chemistry, Faculty of Life Sciences, University of Vienna, Althanstraße 14, 1090 Vienna, Austria
*
Authors to whom correspondence should be addressed.
Molbank 2015, 2015(3), M867; https://doi.org/10.3390/M867
Received: 18 June 2015 / Revised: 17 August 2015 / Accepted: 18 August 2015 / Published: 21 August 2015
Starting from 1-(2-fluorophenyl)-1,3-dihydro-2H-benzimidazol-2-one (1) and (1-bromo-3-chloropropyl)benzene (2), the target compound 3, which represents a precursor for future radiolabeling, is prepared in a three-step synthesis. View Full-Text
Keywords: NET, PET, FAPPI NET, PET, FAPPI
Show Figures

Graphical abstract

MDPI and ACS Style

Neudorfer, C.; Eberherr, N.; Shanab, K.; Holzer, W.; Rami-Mark, C.; Mitterhauser, M.; Wadsak, W.; Spreitzer, H. 1-(3-Amino-1-phenylpropyl)-3-(2-fluorophenyl)-1,3-dihydro-2H-benzimidazol-2-one. Molbank 2015, 2015, M867.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Only visits after 24 November 2015 are recorded.
Back to TopTop